ArticleJCI insight2026

A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention.

Millie O Fullerton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.